Purpose-built STPs for hospitals, nursing homes, and healthcare facilities. Advanced pathogen elimination, pharmaceutical residue removal, and full BMW Rules compliance. Because hospital wastewater demands hospital-grade treatment.
Get a Free Assessment →Hospital wastewater is fundamentally different from domestic sewage. It carries biological hazards, pharmaceutical compounds, and chemical contaminants that pose direct public health risks if inadequately treated.
Hospital wastewater carries concentrated loads of drug-resistant bacteria (MRSA, VRE), viruses (Hepatitis B/C, HIV fragments), and parasites. Pathogen concentrations can be 2–10× higher than domestic sewage. Inadequate treatment risks releasing antimicrobial-resistant organisms into the environment and water supply.
Antibiotics, cytotoxic (anti-cancer) drugs, hormones, anesthetics, and contrast media enter wastewater from patient excretion, spills, and disposal. These micropollutants persist through conventional treatment, disrupting aquatic ecosystems and contributing to antimicrobial resistance in downstream water bodies.
Glutaraldehyde, formaldehyde, chlorhexidine, and iodine-based disinfectants from sterilization, cleaning, and surgical areas enter the waste stream. These chemicals are toxic to biological treatment organisms and require specialized handling before biological treatment stages.
Pathology labs, microbiology departments, and research facilities generate waste containing culture media, chemical reagents, stains, and potentially infectious samples. These high-risk streams require segregation and pre-treatment before entering the main STP.
Nuclear medicine departments using diagnostic isotopes (Tc-99m, I-131, F-18) generate low-level radioactive wastewater. While most isotopes have short half-lives, proper holding tank systems are needed to allow decay before discharge to the STP.
BMW Rules 2016 mandate liquid biomedical waste treatment before discharge. NABH accreditation requires documented STP performance. Municipal sewerage boards impose additional standards for hospital connections. Non-compliance risks facility closure and criminal liability for hospital administrators.
ZEXCORP designs multi-barrier treatment systems that ensure complete pathogen elimination and pharmaceutical residue removal while maintaining compact footprints suitable for hospital campuses.
Combines biological treatment with ultrafiltration membranes providing absolute barrier to bacteria and suspended solids. Produces crystal-clear effluent with BOD <5 mg/L and TSS <2 mg/L. 60% smaller footprint than conventional STP — ideal for space-constrained hospital sites.
Medium-pressure UV systems delivering >40 mJ/cm² dose for 4-log (99.99%) pathogen inactivation. No chemical addition or residual formation. Effective against chlorine-resistant organisms like Cryptosporidium and Giardia. Zero contact time required — compact inline installation.
Powerful oxidant that destroys pharmaceutical residues, micropollutants, and endocrine disruptors that survive biological treatment. Also provides excellent disinfection (5-log kill). Decomposes to oxygen — no harmful residuals. Essential for hospitals with oncology departments generating cytotoxic drug residues.
Sodium hypochlorite dosing system as secondary disinfection barrier. Provides residual disinfection protection in treated water storage and distribution. Automated dosing based on real-time ORP monitoring ensures consistent chlorine residual without over-dosing.
Granular activated carbon (GAC) adsorption for removal of residual pharmaceuticals, disinfectant by-products, color, and odor. Provides final polishing to achieve reuse-quality water. Especially effective for removing antibiotics and hormones that resist biological degradation.
Moving Bed Biofilm Reactor for robust biological treatment of hospital organic loads. High biomass concentration handles fluctuating loads from varying occupancy. Protected biofilm resists toxicity from disinfectant surges. Minimal sludge production reduces handling requirements.
Representative results from ZEXCORP hospital STP installations demonstrating consistent compliance with discharge and reuse standards.
| Parameter | Raw Sewage | Treated Output | Discharge Standard | Removal |
|---|---|---|---|---|
| pH | 6.5 – 8.5 | 7.0 – 7.5 | 6.5 – 9.0 | — |
| BOD (mg/L) | 250 – 450 | < 10 | ≤ 30 | > 97% |
| COD (mg/L) | 500 – 900 | < 50 | ≤ 250 | > 94% |
| TSS (mg/L) | 200 – 400 | < 10 | ≤ 100 | > 97% |
| Fecal Coliform (MPN/100mL) | 10⁶ – 10⁸ | < 100 | ≤ 1,000 | > 99.999% |
| Total Coliform (MPN/100mL) | 10⁷ – 10⁹ | < 500 | ≤ 5,000 | > 99.999% |
| Turbidity (NTU) | 100 – 250 | < 2 | ≤ 10 | > 99% |
From 20-bed nursing homes to 500-bed multi-specialty hospitals — ZEXCORP delivers compact, compliant, and reliable STP solutions with complete BMW Rules documentation support.